Autism Spectrum Disorder
Introduction and Epidemiology
- Autism spectrum disorder (ASD) is a neurodevelopmental disorder with an onset in the early developmental period.
- The disorder is characterized by a triad of qualitative impairments in social behavior, communication, and restricted behavioral patterns, though contemporary diagnostic criteria group social interaction and communication together.
- The global prevalence of ASD is estimated to be between 1% and 2%, with the U.S. Centers for Disease Control and Prevention estimating a prevalence of 1 in 36 children.
- There is a 4:1 male predominance, although emerging evidence suggests prevalence in females may be higher than previously recognized due to "camouflaging" behaviors (hiding social communication difficulties by mimicking others).
- The recurrence rate in siblings is significantly increased, up to 18%, and is particularly high in monozygotic twins.
Etiopathogenesis and Risk Factors
- The etiology of ASD is primarily attributed to disrupted neural connectivity and genetic variations affecting early brain development.
- Neuroanatomic changes include alterations in brain volume, neural cell density in the limbic system, cerebellum, and frontotemporal regions, and abnormalities in the functioning of mirror neurons.
- Early brain development studies indicate "hyperexpansion of cortical surface area" at 6 to 12 months of age, which correlates with later impairment in social skills.
- Genetic causes account for approximately 10% of cases and include single-gene disorders, large genetic deletions or duplications (e.g., 15q11.2 or 16p11.2), and rare recessive mutations.
- An epigenetic model suggests that individuals with genetic vulnerability may be more sensitive to environmental factors.
- There is no scientific evidence to support an association between vaccines or vaccine preservatives and the development of ASD.
| Risk Factor Category | Specific Examples and Associations |
|---|---|
| Genetic Syndromes | Fragile X syndrome, Tuberous sclerosis, Angelman syndrome, Rett syndrome, Smith-Lemli-Opitz syndrome, Timothy syndrome, Joubert syndrome. |
| Metabolic Disorders | Phenylketonuria (untreated), congenital hypothyroidism, mitochondrial disorders. |
| Environmental / Parental | Advanced maternal or paternal age, maternal obesity, short interpregnancy interval, premature birth. |
| Prenatal Exposures | Intrauterine exposure to infections (e.g., rubella, cytomegalovirus). |
Clinical Features (DSM-5 Diagnostic Criteria)
- A diagnosis of ASD requires the fulfillment of specific criteria across two primary domains, with symptoms present in the early developmental period causing clinically significant impairment.
- These disturbances must not be better explained by intellectual disability (ID) or global developmental delay (GDD).
Deficits in Social Communication and Social Interaction
- Deficits in social-emotional reciprocity: Ranges from abnormal social approach and failure of normal back-and-forth conversation, to reduced sharing of interests, emotions, or affect, to a complete failure to initiate or respond to social interactions.
- Deficits in nonverbal communicative behaviors: Manifests as poorly integrated verbal and nonverbal communication, abnormalities in eye contact and body language, deficits in understanding and using gestures, and a total lack of facial expressions.
- Deficits in developing, maintaining, and understanding relationships: Includes difficulties adjusting behavior to suit various social contexts, difficulties in sharing imaginative play or making friends, and an absence of interest in peers.
Restricted, Repetitive Patterns of Behavior, Interests, or Activities
- Stereotyped or repetitive motor movements, use of objects, or speech: Examples include simple motor stereotypies (hand flapping, rocking), lining up toys, flipping objects, echolalia, and idiosyncratic phrases.
- Insistence on sameness and inflexible adherence to routines: Manifests as extreme distress at small changes, difficulties with transitions, rigid thinking patterns, greeting rituals, and the need to take the same route or eat the same food every day.
- Highly restricted, fixated interests: Interests that are abnormal in intensity or focus, such as a strong attachment to or preoccupation with unusual objects, or excessively circumscribed or perseverative interests.
- Hyperreactivity or hyporeactivity to sensory input: Apparent indifference to pain or temperature, adverse responses to specific sounds or textures, excessive smelling or touching of objects, and visual fascination with lights or movement.
DSM-5 Severity Levels
| Severity Level | Social Communication Impairment | Restricted, Repetitive Behaviors |
|---|---|---|
| Level 3: Requiring very substantial support | Severe deficits; very limited initiation of social interactions and minimal response to social overtures. | Inflexibility of behavior markedly interferes with functioning in all spheres; great distress changing focus. |
| Level 2: Requiring substantial support | Marked deficits apparent even with supports in place; limited initiation and abnormal responses to overtures. | Inflexibility appears frequently enough to be obvious to casual observers; interferes with functioning. |
| Level 1: Requiring support | Noticeable impairments without supports; difficulty initiating social interactions; atypical responses. | Inflexibility causes significant interference with functioning in one or more contexts; problems with planning. |
Co-occurring Conditions and Comorbidities
| Domain | Associated Conditions and Clinical Significance |
|---|---|
| Intellectual and Language | Intellectual disability is present in 30โ50% of individuals. Approximately 40% of individuals with ASD remain non-verbal. |
| Behavioral Health | ADHD is the most common comorbidity (40โ70%). Anxiety disorders (social and generalized) affect ~40%. Oppositional defiant disorder (16-28%) and depression (12-70%, mainly in older/high-functioning individuals) also frequently co-occur. |
| Neurologic | Epilepsy occurs in 35-46% of individuals, with two incidence peaks: early childhood and adolescence. Catatonia (autism shutdown disorder) may emerge in adolescence. |
| Gastrointestinal & Nutrition | GI problems (cyclic vomiting, constipation, gastroesophageal reflux disease) affect up to 70%. Avoidant and restrictive food intake disorder (ARFID) occurs in ~21%. Pica is seen in up to 25% of preschool-aged children. |
| Sleep | Sleep problems, including delayed sleep onset and frequent night waking, affect 50โ80%. Abnormal baseline melatonin secretion may contribute. |
| Safety | Wandering/elopement occurs in nearly 50% of children aged 4-10 years, carrying a high risk for near-drowning and traffic-related injuries. Increased risk for self-injury and aggression, particularly in those with limited language. |
Differential Diagnosis
- Global Developmental Delay / Intellectual Disability: Children with ID may display stereotyped behavior; however, their social and communication skills are generally commensurate with their overall cognitive and adaptive functioning.
- Language Disorders: Children with specific language disorders may struggle with social communication, but they do not exhibit the restricted, repetitive behaviors or atypical use of language (e.g., scripting) characteristic of ASD.
- Hearing Impairment: May present with a lack of response to name, but children with hearing loss typically develop normal nonverbal communication and pretend play without repetitive behaviors.
- ADHD: Reduced eye contact may be due to poor attention rather than a lack of social awareness; however, ADHD lacks the impairments in shared enjoyment and social reciprocity.
- Social Anxiety: Shy or anxious children may avoid eye contact and resist change, but they retain social insight and interest without displaying high levels of stereotyped behaviors.
- Landau-Kleffner Syndrome: Presents with an acquired loss of language function (auditory verbal agnosia) and sleep-related epileptic seizures, typically after a period of normal development at 3 to 6 years of age.
Screening Tests for Autism Spectrum Disorder (ASD)
Indications and Timing for Screening
- The American Academy of Pediatrics (AAP) recommends universal developmental screening for all children, with specific autism screening tests administered during health supervision visits at 18 months and 24 months of age.
- Additional targeted screening should occur whenever there is an increased risk for ASD, such as in a child with an older sibling diagnosed with ASD, or whenever a parent, guardian, or early childhood professional expresses concerns regarding the child's development or behavior.
- Screening tests are designed to be low-cost, brief, and standardized so they can be easily implemented in the primary care setting, with interpretation of the results and initiation of referrals handled by the primary care clinician.
Specific Autism Screening Tools
| Screening Test | Target Age Range | Number of Items | Clinical Details |
|---|---|---|---|
| Modified Checklist for Autism in Toddlers, Revised with Follow-up (M-CHAT-R/F) | 16โ48 months | 20 items | Takes 5โ10 minutes to administer; completed by parents; widely considered the best tool and best predictor for the development of ASD. |
| Parent's Observation of Social Interaction (POSI) | Toddlers | 7 items | A brief, autism-specific screening tool completed by parents. |
| Survey of Well-Being of Young Children (SWYC) | 16โ35 months (autism module) | <5 items | A comprehensive survey that includes an abbreviated screening instrument specifically for autism spectrum disorders. |
| Screening Tool for Autism in Toddlers and Young Children (STAT) | 24โ35 months | 12 items (average) | Requires 20โ30 minutes to administer; evaluates key social and communicative behaviors. |
| Social Communication Questionnaire (SCQ) | 4+ years | 40 items (average) | Takes 5โ10 minutes; utilized for older children to assess communication and social functioning. |
Details of the M-CHAT-R/F
- The M-CHAT-R/F is the most frequently utilized screening tool for ASD in primary care settings.
- It is a simple questionnaire completed by parents, with positive answers subsequently validated through a standardized follow-up interview to identify children at true risk.
- While the tool can be used for ages 16 to 48 months, it is most heavily emphasized for the 16 to 30-month window.
- Scoring criteria dictate that children who score $\ge$8, or those who score between 3 and 7 and maintain this score after the follow-up parent interview, are considered at high risk for an ASD diagnosis or other developmental delays and warrant immediate referral.
Broad-Band Screening and Surveillance
- The diagnostic suspicion for ASD may also be raised during routine developmental surveillance using broad-band screening instruments.
- General developmental tools such as the Ages & Stages Questionnaires (ASQ), Pediatric Symptom Checklist (PSC), or Strengths and Difficulties Questionnaire (SDQ) may highlight social-emotional difficulties, communication delays, or behavioral deviations that prompt specific autism screening.
- Clinical "red flags" that should immediately trigger further ASD evaluation include a loss of developmental skills at any age, absence of speech by 15 months (especially without compensatory gestures), and a failure to point to show interesting objects by 18 months.
Diagnostic Approach and Evaluation
- Diagnostic Observational Tools: The Autism Diagnostic Observation Schedule, Second Edition (ADOS-2), Toddler module (ADOS-T), and Childhood Autism Rating Scale, Second Edition (CARS-2) provide structured play-based assessments to evaluate social responsiveness, joint attention, and repetitive behaviors. The Autism Diagnostic Interview-Revised (ADI-R) is a comprehensive clinical interview tool often utilized in research.
- Physical Examination: Must include a detailed neurologic examination, measurement of head circumference (macrocephaly is noted in up to 25% of ASD cases), evaluation for dysmorphic features, and a Wood lamp examination to rule out tuberous sclerosis.
- Audiology: An audiology examination is mandatory to rule out hearing loss.
Genetic and Neurologic Investigations
| Investigation | Indications and Diagnostic Yield |
|---|---|
| Chromosomal Microarray (CMA) | Considered first-tier etiologic testing. Positive in 10โ15% of all ASD individuals, and up to 30% in those with complex presentations (e.g., dysmorphisms, congenital anomalies). |
| Fragile X (FMR1) Testing | Recommended for all males with ASD, and for females with suggestive physical features or a family history of X-linked ID, tremor/ataxia, or premature ovarian failure. |
| MECP2 Testing | Recommended for females with ASD, and for males presenting with hypotonia, drooling, and frequent respiratory infections. |
| PTEN Gene Testing | Indicated for all individuals with ASD and a head circumference greater than 2.5 standard deviations above the mean. |
| Neuroimaging (MRI) | Indicated only for significant developmental regression, seizures, microcephaly, or focal neurologic findings. Not routinely indicated for macrocephaly alone. |
| Electroencephalogram (EEG) | Indicated when there is clinical suspicion of seizures, spells, or significant developmental regression. |
| Whole Exome Sequencing (WES) | Considered if initial genetic testing is negative; identifies single-nucleotide variants and provides a molecular diagnosis in nearly 30% of neurodevelopmental disorders. |
Management
Developmental and Educational Interventions
- Applied Behavioral Analysis (ABA): An evidence-based behavioral framework utilizing direct incremental teaching of skills, positive reinforcement, and careful data collection to build language, cognitive, and emotional skills.
- Developmental Relationship-Based Interventions (DRBI): Parent-mediated interventions (e.g., Floortime) focused on building warm interactions to improve problem-solving and communication.
- Comprehensive Integrated Models: Programs such as the Early Start Denver Model (ESDM) and Joint Attention Symbolic Play Engagement and Regulation (JASPER) integrate behavioral and developmental approaches for young toddlers.
- Structured Educational Approaches: The Treatment and Education of Autistic and Communication Handicapped Children (TEACCH) program utilizes structured teaching, visual schedules, and environmental adjustments to meet the specific needs of children with ASD.
- Speech and Language Therapy: Focuses on vocabulary, comprehension, and pragmatic skills. Augmentative communication approaches (e.g., Picture Exchange Communication System - PECS) facilitate communication and do not inhibit the acquisition of spoken language.
Pharmacological Interventions
- Currently, there are no pharmacological agents approved to treat the core social and communicative deficits of ASD.
- Medications are reserved for managing specific, severe co-occurring conditions that do not respond to behavioral interventions.
| Medication Class | Target Symptoms | Common Side Effects and Monitoring |
|---|---|---|
| Atypical Antipsychotics (Risperidone, Aripiprazole) | FDA-approved for severe irritability, aggression, and self-injurious behavior. | Weight gain, metabolic syndrome, extrapyramidal movements, tardive dyskinesia. Requires laboratory monitoring (lipids, glucose, LFTs). |
| Stimulants (Methylphenidate, Amphetamines) | Hyperactivity, impulsivity, and inattention (comorbid ADHD). | Irritability, emotional lability, reduced appetite, insomnia, exacerbation of stereotypy. Monitor height, weight, BP, HR. |
| Alpha-2 Agonists (Clonidine, Guanfacine) | Hyperactivity, impulsivity, inattention, and sleep-onset difficulties. | Drowsiness, irritability, hypotension, dry mouth. Monitor BP and HR. |
| SSRIs (Sertraline, Fluoxetine) | Anxiety, obsessive-compulsive behaviors, and depression. | Behavioral activation, irritability, agitation, sleep disruption. |
| Melatonin | Sleep-onset insomnia. | Daytime sleepiness, enuresis, headache. |
Complementary and Alternative Medicine (CAM)
- Many CAM therapies lack scientific evidence. High-dose vitamins, chelation therapy, and hyperbaric oxygen are potentially harmful and not recommended.
- Secretin and facilitated communication have strong evidence demonstrating a lack of efficacy.
- For children with highly restrictive diets, standard supplementation with a multivitamin and Vitamin D (400 IU) is indicated. A gluten-free diet may be trialed in cases of documented sensitivity but is not universally recommended for ASD.